May 7: Developing Decision-Grade Real-World Evidence - In Person at ISPOR 2023
event-Short-Courses

May 7, 2023

Back to all short courses

Developing Decision-Grade Real-World Evidence


LEVEL:
Intermediate
TRACK:
Real World Data & Information Systems
LENGTH:
4 Hours | Course runs 1 day

This short course is offered in-person at the ISPOR 2023 conference. Separate registration is required. Visit the ISPOR 2023 website to register and learn more.

Sunday, 7 May 2023 | Course runs 1 Day
8:00AM-12:00PM Eastern Daylight Time (EDT) 

DESCRIPTION

In this course, participants are guided through a hands-on analysis of real-world data to develop decision-grade real-world evidence (RWE) that could be used to support an indication expansion. The first section of the course focuses on what makes RWE “decision-grade.” A review is conducted of the most recent RWE frameworks and guidelines set by regulatory agencies and professional organizations, and case studies are examined in which these guidelines were used in regulatory and HTA approval. The second half of the course is an active workshop where participants use principles from the first half of the course to execute a decision-grade RWE study. Participants are guided step-by-step in using a software platform that enables them to work within a longitudinal US insurance claims database with anonymized patients. After the study has been executed, a discussion on how these results are communicated to decision makers is held. Participants should come with a laptop with Google ChromeTM installed. PREREQUISITE: Students are expected to be familiar with relevant concepts and methodologies for analyzing real-world data, but this course does not require specific programming skills.

Registrants receive a digital course book. Copyright, Trademark and Confidentiality Policies apply.

FACULTY MEMBERS

Sebastian Schneeweiss, MD, ScD
Professor of Medicine and Epidemiology, Harvard Medical School
and Chief, Division of Pharmacoepidemiology
Brigham and Women’s Hospital
Boston, MA, USA
 
Jeremy A. Rassen, ScD
Co-Founder & Chief Scientific Officer
Aetion, Inc.
New York, NY, USA

Shirley Wang, PhD
Associate Professor of Medicine
Division of Pharmacoepidemiology and Pharmacoeconomics
Department of Medicine, Brigham and Women’s Hospital
Harvard Medical School
Boston, MA, USA
 
  

Basic Schedule:
4 Hours | Course runs 1 Day

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×